Detalles de la búsqueda
1.
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Ann Hematol
; 100(8): 2043-2050, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33973053
2.
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.
Haematologica
; 108(10): 2814-2819, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891749
3.
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant.
J Med Econ
; 27(1): 789-795, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727527
4.
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Lancet Oncol
; 13(2): 196-206, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22173060
5.
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Cancer
; 118(19): 4715-24, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22392525
6.
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Leukemia
; 36(10): 2468-2478, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974101
7.
Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder.
Front Immunol
; 13: 994552, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36304469
8.
Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases.
Haematologica
; 96(7): 1067-71, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21719885
9.
IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment.
Transpl Int
; 24(9): 892-903, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21668529
10.
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.
Bone Marrow Transplant
; 56(9): 2118-2124, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864020
11.
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
Transplantation
; 102(5): 868-875, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29189632
12.
Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.
Transplantation
; 102(11): 1914-1923, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29757894
13.
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
J Clin Oncol
; 35(5): 536-543, 2017 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27992268
14.
Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.
J Immunol Res
; 2014: 264723, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24741582
15.
EBV and posttransplantation lymphoproliferative disease: what to do?
Hematology Am Soc Hematol Educ Program
; 2013: 95-102, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24319169
16.
Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
Transplantation
; 93(5): 543-50, 2012 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234349
17.
Therapeutic options in post-transplant lymphoproliferative disorders.
Ther Adv Hematol
; 2(6): 393-407, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23556105
18.
Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network.
Transplantation
; 96(3): e18-9, 2013 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23917690
19.
Haemorrhage due to proteolysis of FXIII and hyperfibrinolysis under vemurafenib treatment of metastatic melanoma.
Thromb Haemost
; 108(4): 798-800, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22918265
20.
Effect of dexamethasone on pulmonary and renal angiotensin-converting enzyme concentration in fetal sheep during late gestation.
Am J Obstet Gynecol
; 189(5): 1467-71, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14634587
Resultados
1 -
20
de 20
1
Próxima >
>>